Drugs & medicalClass II

Rising Pharma Holding, Inc. recalls Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Rising Health, LLC, Saddle Brook, NJ…

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit.

Read the official notice →
Date
2025-03-26
Country
United States
Brand
Rising Pharma Holding
Product
Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663,…
Classification
Class II
Units
Nationwide in the USA.
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Rising Pharma Holding recalls

  1. 2026-07-29
  2. US
    Drugs & medicalClass II

    Rising Pharma Holding, Inc. recalls Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for: Rising Pharma Holdings, Inc.,…

    Presence of Precipitate: medication was crystallizing and particles floating in the bottle

    FDA · DrugRising Pharma Holding, Inc.Nationwide U.S.A.Official notice →
  3. 2026-03-11
  4. US
    Drugs & medicalClass II

    Rising Pharma Holding, Inc. recalls Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc.,…

    Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing

    FDA · DrugRising Pharma Holding, Inc.Nationwide within the U.SOfficial notice →
  5. 2025-10-22
  6. US
    Drugs & medicalClass II

    Rising Pharma Holding, Inc. recalls Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings,…

    Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength Carbidopa, Levodopa, and…

    FDA · DrugRising Pharma Holding, Inc.Distributed Nationwide in the USAOfficial notice →
  7. 2025-01-15
  8. US
    Drugs & medicalClass II

    Rising Pharma Holding, Inc. recalls Duloxetine Delayed-Release Capsules USP 30 mg, a) 30 count (NDC 57237-018-30) and b) 1000 count (NDC 57237-018-99) bottles, Rx only,…

    CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.

    FDA · DrugRising Pharma Holding, Inc.NationwideOfficial notice →
  9. 2024-12-11
  10. US
    Drugs & medicalClass II

    Rising Pharma Holding, Inc. recalls Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30), b) 90 count NDC 57237-019-90 and c) 1000 count (NDC 57237-019-99)…

    CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit

    FDA · DrugRising Pharma Holding, Inc.Nationwide.Official notice →
  11. 2024-07-17
  12. US
    Drugs & medicalClass III

    Rising Pharma Holding, Inc. recalls Diflorasone Diacetate Ointment, USP, 0.05%, 60g tube, Rx only, Mfd. By: Lyne Laboratories, Inc., Brockton, MA 02301; Mfd. For: Rising…

    Failed Impurities/Degradation Specifications: The impurity results at 12 months stability testing,did not conform to the specification limit.

    FDA · DrugRising Pharma Holding, Inc.Nationwide in the USAOfficial notice →
All 9 Rising Pharma Holding recalls →

Other drugs & medical recalls in the United States

  1. 2025-03-26
  2. US
    Drugs & medicalClass I

    One Source Nutrition, Inc, recalls Vitality, Fast Acting Male Enhancement Product, Dietary Supplement, a) One Capsule per Packet, b) 6 capsules per bottle, Xtreme…

    Marketed without an approved NDA/ANDA: Product found to be tainted with undeclared sildenafil and tadalafil.

    FDA · DrugOne Source Nutrition, Inc,Nationwide in the U.S.AOfficial notice →
  3. US
    Drugs & medicalClass II

    MYLAN PHARMACEUTICALS INC recalls Prasugrel Tablets, USP, 5 mg, 30-count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC…

    Failed Dissolution Specifications - low dissolution results

    FDA · DrugMYLAN PHARMACEUTICALS INCUS Nationwide.Official notice →
  4. US
    Drugs & medicalClass II

    Slate Run Pharmaceuticals recalls Cinacalcet Hydrochloride Tablets 60 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by:…

    CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.

    FDA · DrugSlate Run PharmaceuticalsProduct was distributed to 8 distributors who may have further distribute the…Official notice →
  5. 2025-03-20
  6. US
    Drugs & medical

    Woolite Delicates Detergent Recalled by Reckitt Due to Risk of Exposure to Bacteria; Sold Exclusively on Amazon.com

    The recalled products can contain Pseudomonas species bacteria, including Pseudomonas oleovorans, an environmental organism found widely in soil and water. People with weakened immune systems or external medical…

    CPSCReckitt Benckiser LLC, of Parsippany, New JerseyAbout 16,200Official notice →
  7. 2025-03-19
  8. US
  9. US
    Drugs & medicalClass II

    Zimmer, Inc. recalls Z1 Femoral Hip System, Product Number 611777612

    There is a potential design issue with the Z1 Offset Stem Inserter leading to fracturing of the distal tip.

    FDA · DeviceZimmer, Inc.US Nationwide distribution.Official notice →
See all drugs & medical recalls →